
|Articles|July 8, 2008
Thermage to buy Reliant for $87.5 million plus debt
New York - Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
Advertisement
New York
- Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
Thermage is set to pay $25 million in cash and issue $23.6 million shares valued at $62.5 million. Thermage also agreed to assume $7 million in debt and provide $5 million of bridge financing to Reliant.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
3
Practical Approaches to Managing Atopic Dermatitis With Topical Therapies
4
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
5

















